Quince Therapeutics, Inc. (QNCX)
1.09
+0.10
(+9.57%)
USD |
NASDAQ |
May 19, 13:16
Quince Therapeutics Research and Development Expense (Quarterly) : 6.845M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | 75.20M |
| BioXcel Therapeutics, Inc. | 2.792M |
| Gossamer Bio, Inc. | 43.07M |
| Ernexa Therapeutics, Inc. | 1.915M |
| Acurx Pharmaceuticals, Inc. | 0.3415M |